pillbase.ru

Kisqali

Active substance: ribociclib

ribociclib succinate

Centralised EU authorisationActive

Marketing holder: Novartis Europharm Limited

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 3
  • KISQALI
    TABLET, FILM COATED · RIBOCICLIB SUCCINATE 200 mg/1
    0078-0860
    Novartis Pharmaceuticals Corporation
  • KISQALI
    TABLET, FILM COATED · RIBOCICLIB SUCCINATE 200 mg/1
    0078-0867
    Novartis Pharmaceuticals Corporation
  • KISQALI
    TABLET, FILM COATED · RIBOCICLIB SUCCINATE 200 mg/1
    0078-0874
    Novartis Pharmaceuticals Corporation
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208c-fa83-7c19-b808-0465b46915cf,01a1208c-fa89-7c20-aecd-3d20fead3591,01a1208e-0331-79e6-bd75-b849d1f5ce2a;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004213
Registration status
Active
ATC code
L01EF02
Sources
  • product · EMA · EMEA/H/C/004213 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004213 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004213 · Verified 2026-10-09